|

Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.

RECRUITINGN/ASponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Actively Recruiting
PhaseN/A
SponsorCentre hospitalier de l'Université de Montréal (CHUM)
Started2023-02-03
Est. completion2025-12-30
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05719779

Summary

Evaluation of the Tolerance and Benefits of Mandibular Advanced Device (MAD) for Snoring and Sleep Apnea in Patients with Oropharyngeal Cancer (OPC): Mixed Design Study.

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* oropharyngeal cancer diagnosis
* 18 years of age and over
* female or male; ratio of 1/4 toward men
* had received RTH in the Department of Radiation Oncology,
* reporting snoring and/or respiratory cessation complaints during sleep,

Exclusion Criteria:

* pregnant or breastfeeding woman;
* edentation preventing retention of the oral appliance;
* taking opioid or anxiolitic type medications;
* history of major depression,
* uncontrolled hypertension,
* history of stroke;
* under treatment with CPAP for sleep apnea;
* regular and intense orofacial pain;
* under pharmacological treatment for insomnia;
* excessive alcohol or drug use (e.g., cannabis, opioid).

Conditions6

CancerOral CancerOral Squamous Cell CarcinomaPharynx CancerSleep ApneaSnoring

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.